chr16-47083462-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018092.5(NETO2):c.1337G>A(p.Ser446Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,614,192 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018092.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NETO2 | NM_018092.5 | c.1337G>A | p.Ser446Asn | missense_variant | 9/9 | ENST00000562435.6 | NP_060562.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NETO2 | ENST00000562435.6 | c.1337G>A | p.Ser446Asn | missense_variant | 9/9 | 1 | NM_018092.5 | ENSP00000455169.1 | ||
NETO2 | ENST00000303155.9 | c.1316G>A | p.Ser439Asn | missense_variant | 9/9 | 5 | ENSP00000306726.5 | |||
NETO2 | ENST00000562559.5 | c.854G>A | p.Ser285Asn | missense_variant | 5/5 | 3 | ENSP00000454213.1 | |||
NETO2 | ENST00000564667.1 | c.443G>A | p.Ser148Asn | missense_variant | 2/2 | 4 | ENSP00000457133.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251484Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135912
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461888Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727244
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152304Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74476
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2022 | The c.1337G>A (p.S446N) alteration is located in exon 9 (coding exon 9) of the NETO2 gene. This alteration results from a G to A substitution at nucleotide position 1337, causing the serine (S) at amino acid position 446 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at